30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Kuros Biosciences Reports First US and UK Sales of MagnetOs -

Kuros Biosciences announced the first commercial uses of MagnetOs bone graft substitute in the U.S. and U.K., in spinal fusion and scoliosis procedures, respectively. Kuros received FDA 510(k) clearance to market MagnetOs putty as an autograft extender in the posterolateral spine in 3Q17, and gained approval under the CE Mark earlier this year. (Kuros Biosciences, 7/2/18)